Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000526477 | SCV000654555 | likely benign | Hereditary sensory and autonomic neuropathy type 6; Epidermolysis bullosa simplex 3, localized or generalized intermediate, with BP230 deficiency | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001700156 | SCV002007201 | likely benign | not provided | 2021-05-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001700156 | SCV004163665 | likely benign | not provided | 2025-01-01 | criteria provided, single submitter | clinical testing | DST: BP4, BS1 |
Breakthrough Genomics, |
RCV001700156 | SCV005222083 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Clinical Genetics, |
RCV001700156 | SCV001925495 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001700156 | SCV001927534 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001700156 | SCV001958285 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003962588 | SCV004788414 | benign | DST-related disorder | 2019-11-08 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |